The global incidence of basal cell carcinoma is increasing due to prolonged exposure to ultraviolet (UV) radiation, genetic predispositions, and an aging population that is more susceptible to skin ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...

The basal cell carcinoma market is expected to expand over the next decade as rising diagnoses, aging populations and increased UV exposure lift demand. DelveInsight estimates the global market at ...

As a kidney transplant recipient, Paris Malachias was accustomed to dealing with skin cancer. But when a biopsy showed that ...

Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...

Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...

Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or non­melanoma skin cancer, which is also known as keratinocyte ...

June 15, 2012 — Vismodegib (Erivedge) "is the greatest advance in therapy yet" for the treatment of basal cell carcinoma (BCC), according to an editorial published in the June 7 issue of the New ...

Durable, ongoing near-complete response to nivolimab + relatlimab in a 64 year old with locally-advanced BCC after resistance to 26 wks of nivolimab alone. A new study led by researchers at the Johns ...